JP Morgan Chase’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-28,700
Closed -$2.9M 6649
2021
Q4
$2.9M Buy
+28,700
New +$2.93M ﹤0.01% 3529

Other funds holding CRI

JP Morgan Chase's CRI Position: Q1 2026 in Review

JP Morgan Chase increased its Carter's (CRI) stake by 1,057% in Q1 2026, buying an estimated $11M and bringing the position to 330,448 shares worth $11.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2558.

JP Morgan Chase first reported a position in CRI in Q2 2013 and has held it in 51 quarters since. The position peaked at $420M in Q2 2021. 275 funds tracked by Wall St. Rank hold CRI as of Q1 2026.

  • JP Morgan Chase held 330,448 shares of Carter's worth $11.5M as of Q1 2026.
  • JP Morgan Chase bought 301,899 Carter's shares in Q1 2026, an estimated $11M.
  • Carter's made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2558 holding.
  • JP Morgan Chase first reported a position in Carter's in Q2 2013 and has held it in 51 quarters since.
  • JP Morgan Chase's Carter's position peaked at $420M in Q2 2021.
  • 275 funds tracked by Wall St. Rank held Carter's as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.